Research Laboratories Segment to Lead Automated cell counters Market During 2022-2028

According to our latest study on "Automated Cell Counters Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Type and End User," the market is expected to grow from US$ 6,974.29 million in 2021 to US$ 10,365.95 million by 2028; it is estimated to grow at a CAGR of 5.9% from 2022 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.

Research laboratories mainly focus on developing diagnostic and treatments for infectious and chronic diseases. Infectious diseases and clinical microbiology are fascinating and rapidly changing medical fields with ongoing complex challenges. In recent years, a real revolution in infection diagnosis has occurred due to the incorporation of a wide arsenal of techniques. Diagnostic stewardship is essential for the optimization of cell counter techniques and to accomplish their maximum efficiency and profitability. Countries across the globe are focusing on investing in research and development activities for the control of various infectious diseases. For instance, in India, the Department of Biotechnology (DBT), under the Ministry of Science & Technology, invests in the development of indigenous, reliable, rapid, sensitive, specific, cost-effective, and easy to use in a variety of settings diagnostic platforms and technologies, identifying potential targets for developing novel approaches to broad-spectrum interventions, and new strategies for developing immunotherapies, including those based on host responses. In addition, The Infectious Disease Research Institute (IDRI) is a nonprofit US scientific organization to develop vaccines, therapeutics, and diagnostics for various diseases in developing countries. The IDRI has been a partner in the MSD Fellowship for Global Health. MSD Fellows worked with IDRI on developing a global stakeholder engagement strategy and addressing issues associated with HIV R&D as part of the HIV Cure Initiative and developed a strategic plan for the production and commercialization of vaccines and biotherapeutics in African countries. This increase in research for the development of treatment of infectious diseases is driving the growth of the research laboratories segment.

Based on end user, the automated cell counters market is segmented into hospitals, research laboratories, diagnostic centers, and others. The hospital segment is likely to hold the largest share of the market in 2022. However, the research laboratories are expected to register the highest CAGR from 2022 to 2028. The hospital provides healthcare facilities through specialized scientific equipment. The team of trained staff is assigned to deal with the problems associated with modern medical science in the hospital and help restore normal body functions. Various medical research teams are constantly working to introduce innovative therapeutic technologies. Hospitals offer advanced treatment options for patients to treat chronic and infectious diseases. Further, growing government funding for hospitals and rising hospitalization of patients support the growth of the market for the hospitals segment.

Impact of COVID-19 Pandemic on Automated Cell Counters Market

The sudden onset of the COVID-19 outbreak has hampered the life sciences market. However, the automated cell counters market witnessed growth due to the requirement for rapid screening of COVID-19 and other disease screening. Further, increasing research efforts to understand the disease pattern and development of vaccines boosted the growth of the automated cell counters market. The key players introduced new automated cell counters to sustain their market position during the pandemic. For instance, in May 2020, BioTek introduced the Cell Count & Viability App that can be used with its Cytation Cell Imaging Multi-Mode Readers and Lionheart automated imagers. This application allows rapid hemocytometer-based counting of suspended mammalian cells.

Eppendorf; Thermo Fisher Scientific Inc.; Countstar Inc.; Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche Ltd; Chemometec A/S; Aligned Genetics; Beckman Coulter, Inc. (Danaher); Nanoentek; Olympus Corporation; Merck KGaA; Sysmex Corporation; Agilent Technologies, Inc.; Abbott Laboratories; and Nexcelom Bioscience LLC are the key companies operating in the automated cell counters market.

The report segments the automated cell counters market as follows:

The automated cell counters market is segmented into type, end user, and geography. Based on type, the market is segmented into hemocytometers, flow cytometers, electrical impedance, and spectrophotometers. Based on end user, the market is categorized into hospitals, research laboratories, diagnostic centers, and others. By geography, the automated cell counters market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and the Rest of the Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com